menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

State of The Art Treatment for Hepatitis C

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Since 2001, combination therapy with pegylated interferon with ribavirin is considered the standard of care in hepatitis C treatment. In clinical trials, 50 to 60 percent of patients treated with combination therapy achieved a sustained virologic response, or SVR, meaning the virus is undetectable in their blood. Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the state of the art for treatment of Hepatitis C.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Since 2001, combination therapy with pegylated interferon with ribavirin is considered the standard of care in hepatitis C treatment. In clinical trials, 50 to 60 percent of patients treated with combination therapy achieved a sustained virologic response, or SVR, meaning the virus is undetectable in their blood. Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the state of the art for treatment of Hepatitis C.

Facebook Comments

Programs 9/20/21